
PolyRemedy
closedAdvanced wound care solutions leveraging personalized treatment plans and innovative technology.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | $880k | Seed | |
Total Funding | 000k |
Related Content
PolyRemedy specializes in advanced wound care solutions, focusing on personalized treatment plans and innovative technology to improve patient outcomes. The company serves healthcare providers, including hospitals and clinics, by offering tailored wound care management systems that integrate seamlessly into existing medical workflows. Operating in the healthcare technology market, PolyRemedy's business model revolves around the sale and support of its proprietary wound care products and services. Revenue is generated through direct sales, subscriptions for ongoing support, and licensing of its technology. The company's core product includes a comprehensive wound care management system that uses data analytics to customize treatment plans for individual patients, thereby enhancing the efficiency and effectiveness of wound care.
Keywords: wound care, personalized treatment, healthcare technology, patient outcomes, data analytics, hospitals, clinics, medical workflows, proprietary products, subscriptions.